Tag: FDA drug safety
-
FDA Warns of Increased Risk of New Blood Cancers Linked to Tazverik
Tazverik, a prescription cancer drug used to treat certain rare cancers, has recently come under closer scrutiny by the U.S. Food and Drug Administration. In a safety alert, the FDA warned health care providers and patients about an increased risk of developing new blood cancers in people treated with Tazverik. This announcement has raised understandable…
-
FDA Flags Serious Liver Injury Linked to Tavneos (Avacopan)
Tavneos (avacopan) is a prescription medication approved in 2021 to help treat severe active anti‑neutrophil cytoplasmic autoantibody (ANCA)‑associated vasculitis, a rare autoimmune disease that causes inflammation of small blood vessels. For many patients, Tavneos offered a new option to control a difficult and potentially life‑threatening condition. Now, the U.S. Food and Drug Administration (FDA) says…